{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:32:10Z","timestamp":1762018330170,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jiac.2020.12.018","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T21:53:40Z","timestamp":1608674020000},"page":"1072-1075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Two cases of novel coronavirus infection (COVID-19) with transient viral elevation using semi-quantitative real-time reverse transcription PCR and symptom relapse after completion of 10 days of favipiravir treatment"],"prefix":"10.1016","volume":"27","author":[{"given":"Hajime","family":"Tsuboi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Kasamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Sasao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutomo","family":"Kunimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Munakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Tsuchido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanaga","family":"Yamawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Coronavirus 2019-nCoV","key":"10.1016\/j.jiac.2020.12.018_bib1"},{"issue":"11","key":"10.1016\/j.jiac.2020.12.018_bib2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jiac.2020.12.018_bib3","doi-asserted-by":"crossref","first-page":"104859","DOI":"10.1016\/j.phrs.2020.104859","article-title":"Candidate drugs against SARS-CoV-2 and COVID-19","volume":"157","author":"McKee","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jiac.2020.12.018_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","author":"Grein","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.jiac.2020.12.018_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad-spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.jiac.2020.12.018_bib6","doi-asserted-by":"crossref","first-page":"107512","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"Shiraki","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jiac.2020.12.018_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","author":"Cai","year":"2020","journal-title":"Engineering"},{"issue":"1","key":"10.1016\/j.jiac.2020.12.018_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/COH.0000000000000120","article-title":"Review: influence of ART on HIV genetics","volume":"10","author":"Simonetti","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jiac.2020.12.018_bib9","doi-asserted-by":"crossref","first-page":"104412","DOI":"10.1016\/j.jcv.2020.104412","article-title":"Comparison of seven commercial RT-PCR diagnostic kits for COVID-19","volume":"128","author":"van Kasteren","year":"2020","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jiac.2020.12.018_bib10","doi-asserted-by":"crossref","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.jiac.2020.12.018_bib11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jiac.2020.12.018_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1293.2008.00650.x","article-title":"Factors associated with viral rebound among highly treatment-experienced HIV-positive patient who have achieved viral suppression","volume":"10","author":"Smith","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.jiac.2020.12.018_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12981-016-0100-4","article-title":"Factors associated with HIV viral load \u201cblips\u201d and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case-control study","volume":"13","author":"Farmer","year":"2016","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.jiac.2020.12.018_bib14","article-title":"RV254\/SEARCH010 Study Group. Viral blips after treatment initiation during acute HIV infection","author":"Crowell","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.12.018_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12879-016-1628-6","article-title":"Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels","volume":"16","author":"S\u00f6rstedt","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2020.12.018_bib16","article-title":"Factors associated with prolonged viral RNA shedding in patients with COVID-19","author":"Xu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.12.018_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa398","article-title":"PCR assays turned positive in 25 discharged COVID-19 patients","author":"Yuan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.12.018_bib18","first-page":"101120","article-title":"Detection of SARS-CoV-2 by bronchoscopy after negative nasopharyngeal testing: stay vigilant for COVID-19","volume":"30","author":"Ramos","year":"2020","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.jiac.2020.12.018_bib19","article-title":"Neutralizing antibody response in mild COVID-19","volume":"28","author":"van der Heide","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jiac.2020.12.018_bib20","doi-asserted-by":"crossref","first-page":"104476","DOI":"10.1016\/j.jcv.2020.104476","article-title":"Evaluation of the commercially available LightMix\u00ae Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection","volume":"129","author":"Yip","year":"2020","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jiac.2020.12.018_bib21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s40121-020-00324-3","article-title":"A\u00a0systematic review of the clinical utility of cycle threshold values in the context of COVID-19","volume":"9","author":"Rao","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jiac.2020.12.018_bib22","doi-asserted-by":"crossref","first-page":"2001483","DOI":"10.2807\/1560-7917.ES.2020.25.32.2001483","article-title":"Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020","volume":"25","author":"Singanayagam","year":"2020","journal-title":"Euro Surveill"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20304530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20304530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:58Z","timestamp":1761159778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20304530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1341321X20304530"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.12.018","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two cases of novel coronavirus infection (COVID-19) with transient viral elevation using semi-quantitative real-time reverse transcription PCR and symptom relapse after completion of 10 days of favipiravir treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}